PHOTO
Abu Dhabi: Mubadala Investment Company, through its healthcare arm, today signed a memorandum of understanding (MOU) with Nirvana Travel and Tourism to formalize their intention to collaborate on projects that will support a key Abu Dhabi Vision 2030 objective of establishing the emirate as a leading medical tourism destination.
The areas of collaboration will focus on potential visitors from the GCC, MENA, Russia, China and India, and will include aspects such as creating attractive and all-inclusive medical tourism packages, as well as exploring joint marketing and business opportunities.
Commenting on the collaboration, Abdulla Abdul Aziz Al Shamsi, Head of Mubadala Healthcare, said: “By working together, Mubadala and Nirvana can ensure that patients will experience only the highest standards across the full spectrum of treatment and travel, thus helping cement Abu Dhabi’s reputation as the destination of choice for healthcare.”
Alaa Al Ali, Nirvana CEO, said: “Abu Dhabi’s huge investments into medical tourism have significantly boosted the sector and created numerous opportunities for us to enhance it. Cooperation between government agencies and partnership with the private sector contribute to making the capital a viable international medical hub. Nirvana and Mubadala will work together to meet the needs of patients drawn from abroad thus complementing Mubadala’s efforts to enhance the local healthcare sector utilizing existing healthcare expertise and the advanced infrastructure found here.”
Al Ali added: “Many factors qualify Abu Dhabi to become one of the most sophisticated and sustainable therapeutic tourism destinations in the world. These include the emirate’s strategic location, the existing world-class healthcare providers and expertise, a strong legislation and regulation framework, in addition to the flourishing local economic and tourism sectors. In fact, Abu Dhabi attracts patients from more than 80 countries, which demonstrates the exceptional growth in the capital. We are optimistic and eager to make Abu Dhabi a key strategic market player worldwide, by keeping track of medical trends and factors that fuel the development of the medical tourism sector.”
The partnership between medical and tourism entities follows the example set by Abu Dhabi’s Department of Health and Department of Culture and Tourism. As part of their collaboration, the departments have jointly set up a patient portal that will serve as a one‐stop shop where potential medical tourists can find useful information on the healthcare providers and medical tourism packages, to visa applications and accommodation.
Al Shamsi added: “Through its tremendous support and by focusing on the combination of superior medical care and Abu Dhabi’s highly regarded tourism industry, the government has established a framework for extensive cooperation between stakeholders that will secure the emirate’s position as a leading medical tourism destination.
“This is the first of many partnerships we intend to establish to promote sustainable growth in medical tourism, in line with Abu Dhabi Economic Vision 2030 and efforts to diversify our economy.”
Mubadala's integrated healthcare network includes Cleveland Clinic Abu Dhabi, Healthpoint, Imperial College London Diabetes Centre, National Reference Laboratory, Abu Dhabi Telemedicine Centre, Capital Health Screening Centre and Amana Healthcare. Mubadala Healthcare has plans for continued expansion to better serve an increasing number of domestic and international patients.
‐ENDS‐
About Mubadala Investment Company
Mubadala Investment Company actively manages a worldwide portfolio supporting the vision of a globally integrated and diversified economy, through sustainable returns to its shareholder, the Government of Abu Dhabi. In March 2018, Abu Dhabi Investment Council (ADIC) joined the Group.
Mubadala’s US $225 billion (AED 830 billion) portfolio spans five continents with interests in aerospace, ICT, semiconductors, metals and mining, renewable energy, oil and gas, petrochemicals, utilities, healthcare, real estate, defense services, pharmaceuticals and medical technology, agribusiness and a global portfolio of financial holdings. Mubadala is a trusted partner, an engaged shareholder and a responsible global company that is committed to ethics and world‐class standards.
For more information about Mubadala, please visit: www.mubadala.com.
About Nirvana Travel and Tourism
Nirvana Travel & Tourism was established in 2007. In the past few years we have become the number one full-fledged tour operator company in Abu Dhabi and the UAE. Our intention is to become the most well-known tour operator company in the world.
Nirvana Travel & Tourism is currently offering its services to a vast category of accounts including the governmental and semi-governmental accounts in the UAE. Nirvana act in good faith and a transparent manner has allowed for a steady growth throughout the years. With over 450 employees Nirvana exercises a level of skill, care and diligence as expected of a first-class tour operator company.
Our offices can be found in over 30 different locations throughout Abu Dhabi, Al Ain, Dubai and Ras Al Khaimah. We have recently extended and expanded our reach by opening and operating offices in China, Spain, Egypt, UK and Saudi Arabia. Within the few next years we are expecting to serve other locations such as Australia and The United States of America.
However, we aim to spread our wings all over the globe and reach even more international clientele within the next coming years.
For more information:
info@ntravel.ae , www.ntravel.ae , +971 2 304 3322
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
